Literature DB >> 14740000

Melatonin as an antioxidant: biochemical mechanisms and pathophysiological implications in humans.

Russel J Reiter1, Dun-Xian Tan, Juan C Mayo, Rosa M Sainz, Josefa Leon, Zbigniew Czarnocki.   

Abstract

This brief resume enumerates the multiple actions of melatonin as an antioxidant. This indoleamine is produced in the vertebrate pineal gland, the retina and possibly some other organs. Additionally, however, it is found in invertebrates, bacteria, unicellular organisms as well as in plants, all of which do not have a pineal gland. Melatonin's functions as an antioxidant include: a), direct free radical scavenging, b), stimulation of antioxidative enzymes, c), increasing the efficiency of mitochondrial oxidative phosphorylation and reducing electron leakage (thereby lowering free radical generation), and 3), augmenting the efficiency of other antioxidants. There may be other functions of melatonin, yet undiscovered, which enhance its ability to protect against molecular damage by oxygen and nitrogen-based toxic reactants. Numerous in vitro and in vivo studies have documented the ability of both physiological and pharmacological concentrations to melatonin to protect against free radical destruction. Furthermore, clinical tests utilizing melatonin have proven highly successful; because of the positive outcomes of these studies, melatonin's use in disease states and processes where free radical damage is involved should be increased.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14740000     DOI: 0350041129

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  114 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

2.  In vitro, melatonin treatment decreases nitric oxide levels in murine splenocytes cultured with the venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Eddy Meleán; Ernesto Bonilla; Julia Arias; Luz Marina Espina; Leonor Chacin-Bonilla; Yraima Larreal; Merybell Maldonado; Florencio Añez
Journal:  Neurochem Res       Date:  2005-11       Impact factor: 3.996

Review 3.  Highly reactive oxygen species: detection, formation, and possible functions.

Authors:  Wolfhardt Freinbichler; Maria A Colivicchi; Chiara Stefanini; Loria Bianchi; Chiara Ballini; Bashkim Misini; Peter Weinberger; Wolfgang Linert; Damir Varešlija; Keith F Tipton; Laura Della Corte
Journal:  Cell Mol Life Sci       Date:  2011-05-02       Impact factor: 9.261

4.  Melatonin Supplementation Ameliorates Energy Charge and Oxidative Stress Induced by Acute Exercise in Rat Heart Tissue.

Authors:  Behzat Cimen; Ali Uz; Ihsan Cetin; Leyla Cimen; Aysun Cetin
Journal:  Acta Cardiol Sin       Date:  2017-09       Impact factor: 2.672

Review 5.  Lipoic Acid and Other Antioxidants as Therapies for Multiple Sclerosis.

Authors:  Carin Waslo; Dennis Bourdette; Nora Gray; Kirsten Wright; Rebecca Spain
Journal:  Curr Treat Options Neurol       Date:  2019-05-06       Impact factor: 3.598

6.  Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats.

Authors:  Qing-hua Zhang; Zhan-song Zhou; Gen-sheng Lu; Bo Song; Jian-xin Guo
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

7.  Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.

Authors:  Jie Wen; Prasanth S Ariyannur; Rachel Ribeiro; Mikiei Tanaka; John R Moffett; Batool F Kirmani; Aryan M A Namboodiri; Yumin Zhang
Journal:  J Neuroimmune Pharmacol       Date:  2016-08-25       Impact factor: 4.147

8.  Non-surgical periodontal therapy influences salivary melatonin levels.

Authors:  Kristina Bertl; Angelika Schoiber; Hady Haririan; Markus Laky; Irene Steiner; W D Rausch; Oleh Andrukhov; Xiaohui Rausch-Fan
Journal:  Clin Oral Investig       Date:  2012-07-31       Impact factor: 3.573

9.  The anti-inflammatory effect of melatonin on methamphetamine-induced proinflammatory mediators in human neuroblastoma dopamine SH-SY5Y cell lines.

Authors:  Kannika Permpoonputtana; Piyarat Govitrapong
Journal:  Neurotox Res       Date:  2012-08-18       Impact factor: 3.911

10.  Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients.

Authors:  Richard Rosen; Dan-Ning Hu; Violete Perez; Katy Tai; Guo-Pei Yu; Min Chen; Paul Tone; Steven A McCormick; Joseph Walsh
Journal:  Mol Vis       Date:  2009-08-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.